Does West Nile virus infection cause hepatic injury?

West Nile Virus Does Cause Hepatic Injury

Yes, West Nile virus (WNV) causes hepatic injury, though it is relatively uncommon and typically manifests as transient liver enzyme elevations rather than fulminant hepatic failure. The evidence demonstrates that approximately 20% of WNV-infected patients exhibit abnormal liver function tests, with hepatic involvement ranging from mild transaminase elevations to rare cases of severe hepatitis 1, 2.

Mechanisms and Pathophysiology

WNV demonstrates hepatotropic properties through multiple mechanisms:

• Direct viral effects: Experimental studies show WNV antigens expressed in hepatic capillary endothelium and hepatocyte cytoplasm, with pronounced dystrophic changes in hepatic parenchyma 3
• Metabolic reprogramming: Despite absence of detectable viral replication in liver tissue, WNV infection causes significant hepatic transcriptomic changes affecting inflammation, immunity, and lipid metabolism 1
• Steatosis development: Approximately one-third of WNV-infected animals develop hepatic steatosis, with documented increases in sphingolipids, triacylglycerols, and cholesteryl esters 1

Clinical Spectrum of Hepatic Involvement

The hepatic manifestations vary considerably:

Mild to Moderate Injury (Most Common)

• Transient AST and ALT elevations
• Generally self-limited, requiring no specific treatment
• More common in severe systemic disease than mild cases

Severe Hepatitis (Rare)

• Fulminant hepatitis has been documented, particularly in pediatric cases 4
• Histologic findings include hepatitis, lymphoid depletion, splenic and hepatic hemosiderosis 5
• Can occur as isolated hepatitis without neuroinvasive disease 6

Clinical Pitfalls and Diagnostic Considerations

Critical caveat: When evaluating liver enzyme elevations in WNV patients, consider alternative explanations:

• Myositis: When AST significantly exceeds ALT, suspect muscle involvement rather than primary hepatic injury 7
• Drug-induced liver injury: Many patients receive potentially hepatotoxic medications
• Ischemic hepatitis: Can occur in severe systemic illness
• Cytokine release syndrome: May contribute to liver dysfunction

Diagnostic Approach

When WNV is suspected with abnormal liver function:

1. Obtain baseline serologies: Test for hepatitis B surface antigen and anti-hepatitis C virus antibody to exclude viral hepatitis 7
2. Pattern recognition: Determine if AST > ALT (suggests myositis) or hepatocellular pattern
3. WNV-specific testing: IgM testing of serum/CSF, with confirmatory neutralizing antibody testing
4. Monitor for progression: Serial liver function tests to distinguish transient from progressive injury

Management Implications

Hepatic dysfunction does not contraindicate WNV-specific supportive care or investigational treatments 7. However:

• Regular monitoring of liver function tests is mandatory regardless of baseline values
• If liver function continues to deteriorate, systematically evaluate other causes
• The hepatic dysfunction is generally transient and does not require specific hepatic-directed treatment 7

Long-term Considerations

The discovery of metabolic reprogramming in the liver during WNV infection 1 suggests that hepatic involvement may be more significant than previously recognized. The development of steatosis in one-third of infected animals warrants attention to liver function during acute infection and potentially during follow-up, particularly in patients with pre-existing liver disease or metabolic syndrome.

Bottom line: While neuroinvasive disease dominates WNV clinical presentations, hepatic injury occurs in approximately 20% of patients and ranges from mild transaminase elevations to rare fulminant hepatitis. The liver's metabolic reprogramming during infection may have underappreciated clinical implications that warrant monitoring, though most hepatic dysfunction resolves spontaneously without specific intervention.